Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
- PMID: 15546503
- DOI: 10.1111/j.1349-7006.2004.tb02195.x
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
Abstract
BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predispose to breast and ovarian cancers. Intensive research has shown that BRCA proteins are involved in a multitude of pivotal cellular processes. In particular, both genes contribute to DNA repair and transcriptional regulation in response to DNA damage. Recent studies suggest that BRCA proteins are required for maintenance of chromosomal stability, thereby protecting the genome from damage. New data also show that BRCAs transcriptionally regulate some genes involved in DNA repair, the cell cycle, and apoptosis. Many of these functions are mediated by a large number of cellular proteins that interact with BRCAs. The functions of BRCA proteins are also linked to distinct and specific phosphorylation events; however, the extent to which phosphorylation-activated molecular pathways contribute to tumor suppressor activity remains unclear. Finally, the reasons why mutations in BRCA genes lead to the development of breast and ovarian cancers are not clearly understood. Elucidation of the precise molecular functions of BRCAs is expected to improve our understanding of hereditary as well as sporadic mammary carcinogenesis.
Similar articles
-
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.Hum Mol Genet. 2001 Apr;10(7):705-13. doi: 10.1093/hmg/10.7.705. Hum Mol Genet. 2001. PMID: 11257103 Review.
-
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.Front Biosci (Landmark Ed). 2014 Jan 1;19(4):605-18. doi: 10.2741/4230. Front Biosci (Landmark Ed). 2014. PMID: 24389207 Free PMC article. Review.
-
Cancer susceptibility and the functions of BRCA1 and BRCA2.Cell. 2002 Jan 25;108(2):171-82. doi: 10.1016/s0092-8674(02)00615-3. Cell. 2002. PMID: 11832208 Review.
-
BRCA1 gene in breast cancer.J Cell Physiol. 2003 Jul;196(1):19-41. doi: 10.1002/jcp.10257. J Cell Physiol. 2003. PMID: 12767038 Review.
-
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.Carcinogenesis. 2010 Jun;31(6):961-7. doi: 10.1093/carcin/bgq069. Epub 2010 Apr 16. Carcinogenesis. 2010. PMID: 20400477 Review.
Cited by
-
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report.Thorac Cancer. 2024 Mar;15(8):667-671. doi: 10.1111/1759-7714.15237. Epub 2024 Feb 7. Thorac Cancer. 2024. PMID: 38323364 Free PMC article.
-
The effect of human umbilical cord mesenchymal stem cells conditioned medium combined with tamoxifen drug on BRCA1 and BRCA2 expression in breast cancer mouse models.Mol Biol Rep. 2024 Feb 1;51(1):241. doi: 10.1007/s11033-023-08926-z. Mol Biol Rep. 2024. PMID: 38300337
-
Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.Aging (Albany NY). 2024 Jan 13;16(2):1077-1095. doi: 10.18632/aging.205366. Epub 2024 Jan 13. Aging (Albany NY). 2024. PMID: 38224491 Free PMC article.
-
Copper Chaperone for Superoxide Dismutase Subtypes as a Prognostic Marker in Luminal B Breast Cancer.Clin Med Insights Oncol. 2024 Jan 4;18:11795549231219239. doi: 10.1177/11795549231219239. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 38187458 Free PMC article.
-
ER-positive and BRCA2-mutated breast cancer: a literature review.Eur J Med Res. 2024 Jan 6;29(1):30. doi: 10.1186/s40001-023-01618-1. Eur J Med Res. 2024. PMID: 38184581 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
